CTS (CTS)
(Delayed Data from NYSE)
$47.99 USD
-0.58 (-1.19%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $47.98 -0.01 (-0.02%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for CTS Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 550 | 587 | 513 | 424 | 469 |
Cost Of Goods | 360 | 376 | 328 | 285 | 311 |
Gross Profit | 191 | 211 | 185 | 139 | 158 |
Selling & Adminstrative & Depr. & Amort Expenses | 116 | 118 | 108 | 94 | 104 |
Income After Depreciation & Amortization | 75 | 93 | 76 | 45 | 54 |
Non-Operating Income | 3 | -10 | -135 | 4 | -1 |
Interest Expense | 3 | 2 | 2 | 3 | 3 |
Pretax Income | 75 | 81 | -61 | 45 | 50 |
Income Taxes | 15 | 21 | -19 | 11 | 14 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 61 | 60 | -42 | 35 | 36 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 61 | 60 | -42 | 35 | 36 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 104 | 123 | 103 | 72 | 78 |
Depreciation & Amortization (Cash Flow) | 29 | 30 | 27 | 27 | 25 |
Income After Depreciation & Amortization | 75 | 93 | 76 | 45 | 54 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 31.58 | 32.24 | 32.33 | 32.58 | 33.11 |
Diluted EPS Before Non-Recurring Items | 2.22 | 2.46 | 1.12 | 1.12 | 1.45 |
Diluted Net EPS (GAAP) | 1.92 | 1.85 | -1.30 | 1.06 | 1.09 |
Fiscal Year end for CTS Corporation falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 130.16 | 125.75 | 124.69 | 134.55 | 145.18 |
Cost Of Goods | 83.79 | 80.66 | 82.63 | 88.15 | 94.44 |
Gross Profit | 46.37 | 45.09 | 42.06 | 46.40 | 50.74 |
SG&A, R&D, and Dept/Amort Expenses | 28.61 | 30.55 | 25.81 | 28.21 | 32.31 |
Income After SG&A, R&D, and Dept/Amort Expenses | 17.76 | 14.54 | 16.25 | 18.19 | 18.43 |
Non-Operating Income | 0.84 | -0.08 | 2.19 | 1.55 | -1.53 |
Interest Expense | 0.83 | 0.80 | 0.82 | 1.00 | 0.82 |
Pretax Income | 17.77 | 13.66 | 17.63 | 18.74 | 16.08 |
Income Taxes | 3.06 | 2.54 | 2.31 | 4.77 | 3.18 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 14.71 | 11.12 | 15.32 | 13.97 | 12.90 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 14.71 | 11.12 | 15.32 | 13.97 | 12.90 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 30.73 | 30.99 | 31.24 | 31.51 | 31.69 |
Diluted EPS Before Non-Recurring Items | 0.54 | 0.47 | 0.47 | 0.54 | 0.59 |
Diluted Net EPS (GAAP) | 0.48 | 0.36 | 0.49 | 0.44 | 0.41 |